CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-15 | EDGEMOND JAMES CFO AND TREASURER | Option exercise 10b5-1 | +3,517 | $146.03 | $514K | 11,659 |
| 2025-12-15 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −160 | $491.53 | $79K | 11,499 |
| 2025-12-15 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −840 | $492.81 | $414K | 10,659 |
| 2025-12-15 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −561 | $493.70 | $277K | 10,098 |
| 2025-12-15 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −360 | $495.02 | $178K | 9,738 |
| 2025-12-15 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −520 | $495.90 | $258K | 9,218 |
| 2025-12-15 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −200 | $496.97 | $99K | 9,018 |
| 2025-12-15 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −395 | $498.09 | $197K | 8,623 |
| 2025-12-15 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −240 | $499.31 | $120K | 8,383 |
| 2025-12-15 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −241 | $500.30 | $121K | 8,142 |
| 2025-12-15 | EDGEMOND JAMES CFO AND TREASURER | Option exercise · Stock Option 10b5-1 | −3,517 | 0 | ||
| 2025-12-15 | PATUSKY CHRISTOPHER Director | Option exercise | +1,000 | $101.80 | $102K | 2,490 |
| 2025-12-15 | PATUSKY CHRISTOPHER Director | Sale | −1,000 | $495.95 | $496K | 1,490 |
| 2025-12-15 | PATUSKY CHRISTOPHER Director | Option exercise · Stock Option | −1,000 | 3,910 | ||
| 2025-12-15 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-12-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −500 | $491.77 | $246K | 3,630 |
| 2025-12-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,500 | $495.14 | $1.7M | 130 |
| 2025-12-15 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −4,000 | 14,000 | ||
| 2025-12-12 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-12-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,100 | $489.95 | $539K | 3,030 |
Page 169 of 171 · 3,408 trades